Sarepta (SRPT) PT Lowered to $23 at Baird as FDA Digs in for a Fight on Eteplirsen
Go back to Sarepta (SRPT) PT Lowered to $23 at Baird as FDA Digs in for a Fight on Eteplirsen| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 20.67 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.67 | 52 Week High | $63.73 | |||
| Open | $20.23 | 52 Week Low | $8.00 | |||
| Day High | $21.75 | P/E | N/A | |||
| Day Low | $19.97 | EPS | $-5.69 | |||
| Volume | 288 | |||||
